Breast cancer in the elderly-Should it be treated differently?
Status PubMed-not-MEDLINE Language English Country Poland Media electronic
Document type Journal Article, Review
PubMed
24381744
PubMed Central
PMC3863252
DOI
10.1016/j.rpor.2012.05.005
PII: S1507-1367(12)00083-1
Knihovny.cz E-resources
- Keywords
- Breast cancer, Cancer treatment, Elderly, Old age,
- Publication type
- Journal Article MeSH
- Review MeSH
Breast cancer risk increases with age and about a third of female breast cancers are diagnosed in patients aged older than 70. Breast cancer in the elderly has, however, poorer outcome with lower survival rate compared to younger subjects. This may be partly explained by the delay in diagnosis and the 'under-treatment' of elderly breast cancer patients. In this review I try to provide recommendations for screening, surgery, radiotherapy, (neo)adjuvant hormone treatment and chemotherapy, and also the treatment of metastatic disease. Since large randomised trials usually exclude elderly patients with breast cancer, there is still an insufficient evidence for the treatment of such patients.
See more in PubMed
Gennari R., Curigliano G., Rotmensz N. Breast carcinoma in elderly women – features of disease presentation, choice of local and systemic treatments compared with younger postmenopausal patients. Cancer. 2004;101:1302–1310. PubMed
Spazzapan S., Crivellari D., Bedard P. Therapeutic management of breast cancer in the elderly. Expert Opin Pharmacother. 2011;12(April (6)):945–960. PubMed
Singletary S.E., Shallenberger R., Guinee V.F. Breast cancer in the elderly. Ann Surg. 1993;218:667–671. PubMed PMC
Wildiers H., Kunkler I., Biganzoli L. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol. 2007;8:1101–1115. PubMed
Cardia J., Calçada C., Pereira H. Treatment of lung cancer in the elderly: Influence of comorbidity on toxicity and survival. Rep Pract Oncol Radiother. 2011;16(2):45–48. PubMed PMC
Louwman W.J., Janssen-Heijnen M.L.G., Houterman S. Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer. 2005;41:779–785. PubMed
Extermann M., Aapro M., Bernabei R.B. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG) Crit Rev Oncol Hematol. 2005;55:241–252. PubMed
Audisio R.A. The surgical risk of elderly patients with cancer. Surg Oncol. 2004;13:169–173. PubMed
Fennessy M., Bates T., MacRae K. Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer. Br J Surg. 2004;91:699–704. PubMed
Pierga J.Y., Girre V., Laurence V. Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age. Breast. 2004;13:369–375. PubMed
Balducci L., Extermann M. Cancer and aging: an evolving panorama. Hematol Oncol Clin North Am. 2000;14:1–16. PubMed
Repetto L. Greater risks of chemotherapy toxicity in elderly patients with cancer. J Support Oncol. 2003;1(Suppl. 2):18–24. PubMed
Barthélémy P., Heitz D., Mathelin C. Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals. Crit Rev Oncol Hematol. 2011;79(2):196–204. PubMed
Muss H.B., Woolf S., Berry D. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA. 2005;293:1073–1081. PubMed
Figueiredo M.I., Cullen J., Hwang Y.T. Breast cancer treatment in older women: does getting what you want improve your long-term body image and mental health? J Clin Oncol. 2004;22:4002–4009. PubMed
Barni S., Cabiddu M., Petrelli F. Benefit of adjuvant chemotherapy in elderly ER-negative breast cancer patients: benefits and pitfalls. Expert Rev Anticancer Ther. 2010;10(2):185–198. PubMed
Talarico L., Chen G., Pazdur R. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. JCO. 2004;22(22):4626–4631. PubMed
Clarke M., Collins R., Darby S. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet. 2005;366:2087–2106. PubMed
Cutuli B. Breast cancer irradiation in elderly. Cancer Radiother. 2009;(6–7):615–622. PubMed
Smith B.D., Gross C.P., Smith G.L. Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst. 2006;98:681–690. PubMed
Hughes K.S., Schnaper L.A., Berry D. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;351:971–977. PubMed
EBCTCG Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–1717. PubMed
Silliman R.A., Guadagnoli E., Rakowski W. Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer. J Clin Oncol. 2002;20:2680–2688. PubMed
Blackman S.B., Lash T.L., Fink A.K. Advanced age and adjuvant tamoxifen prescription in early-stage breast carcinoma patients. Cancer. 2002;95:2465–2472. PubMed
Kudachadkar R., O’Regan R.M. Aromatase inhibitors as adjuvant therapy for postmenopausal patients with early stage breast cancer. CA Cancer J Clin. 2005;55:145–163. PubMed
Eastell R., Adams J.E., Coleman R.E. Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial. J Clin Oncol. 2008;26:1051–1057. PubMed
Partridge A.H., Wang P.S., Winer E.P., Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 2003;21:602–606. PubMed
Mauri D., Polyzos N.P., Salanti G., Pavlidis N., Ioannidis J.P. Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer. J Natl Cancer Inst. 2008;100(24):1780–1791. PubMed
Schofield P., Carey M., Love A., Nehill C., Wein S. ‘Would you like to talk about your future treatment options’? Discussing the transition from curative cancer treatment to palliative care. Palliat Med. 2006;20:397–406. PubMed
Holmes C.E., Muss H.B. Diagnosis and treatment of breast cancer in the elderly. CA Cancer J Clin. 2003;53:227–244. PubMed
Disease specific substrates in cancer cachexia - Reality and anticipation